<DOC>
	<DOCNO>NCT00516113</DOCNO>
	<brief_summary>The objective study explore onset action serotonin reuptake inhibitor use treat premenstrual dysphoric disorder</brief_summary>
	<brief_title>A Placebo-Controlled Study Investigate Onset Action Paroxetine Premenstrual Dysphoria</brief_title>
	<detailed_description>Whereas serotonin reuptake inhibitor ( SRIs ) usually require week treatment effectively counteract depress mood anxiety , several study suggest may reduce symptom irritability anger rapidly . In line , SRIs show reduce certain symptom , include irritability , woman premenstrual dysphoric disorder ( PMDD ) drug administer ovulation menstruation , indicate onset action 10 day less . How fast effect appear term hour day , however , know . The objective study explore issue .</detailed_description>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Premenstrual Dysphoric Disorder</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>The patient participate ongoing placebocontrolled trial regard effect paroxetine PMD ; include trial , must fulfil diagnostic criterion AC PMDD DSMIV certain inclusion exclusion criterion list appendix 1 . The patient ) give paroxetine previous trial , b ) report `` much improve '' `` much improve '' treatment , c ) display mark reduction VASrated irritability treatment , ) report found sideeffects tolerable . The patient display least 50 % increase VASrated irritability luteal phase ( mean last five day prior menses ) compare follicular phase ( day 610 ) one cycle pretreatment symptom rating ( without medication ) . The patient give write informed consent participate study . Any concomitant psychiatric disorder SRIs know effective . Any concomitant psychiatric disorder , investigator 's opinion , would render patient unsuitable study . Any somatic disorder , investigator 's opinion , would render patient unsuitable study . Any ongoing medication , opinion investigator , would render patient unsuitable study . Examples medication preclude participation study : 1 ) psychotropic drug , exception occasional use hypnotic , 2 ) hormonal preparation , exception thyroid hormone , 3 ) anticoagulant , 4 ) 5HT1D agonist . Occasional use analgesic compound preclude participation . Patient characteristic , opinion investigator , likely reduce compliance protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>paroxetine</keyword>
	<keyword>onset action</keyword>
	<keyword>serotonin reuptake inhibitor</keyword>
</DOC>